Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 2
2012 2
2014 2
2015 1
2016 3
2017 7
2019 7
2020 5
2021 5
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM; SENSCIS Trial Investigators. Distler O, et al. N Engl J Med. 2019 Jun 27;380(26):2518-2528. doi: 10.1056/NEJMoa1903076. Epub 2019 May 20. N Engl J Med. 2019. PMID: 31112379 Free article. Clinical Trial.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators. Maher TM, et al. JAMA. 2023 May 9;329(18):1567-1578. doi: 10.1001/jama.2023.5355. JAMA. 2023. PMID: 37159034 Free PMC article.
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
Ruan P, Todd JL, Zhao H, Liu Y, Vinisko R, Soellner JF, Schmid R, Kaner RJ, Luckhardt TR, Neely ML, Noth I, Porteous M, Raj R, Safdar Z, Strek ME, Hesslinger C, Palmer SM, Leonard TB, Salisbury ML. Ruan P, et al. Among authors: luckhardt tr. Respir Res. 2023 May 31;24(1):141. doi: 10.1186/s12931-023-02435-0. Respir Res. 2023. PMID: 37344825 Free PMC article.
Measures of Frailty in Chronic Lung Diseases.
Luckhardt T, Thannickal VJ. Luckhardt T, et al. Ann Am Thorac Soc. 2017 Aug;14(8):1266-1267. doi: 10.1513/AnnalsATS.201706-420ED. Ann Am Thorac Soc. 2017. PMID: 28763264 Free PMC article. No abstract available.
Preoperative Evaluation of Patients With Interstitial Lung Disease.
Patel NM, Kulkarni T, Dilling D, Scholand MB; Interstitial and Diffuse Lung Disease Network Steering Committee. Patel NM, et al. Chest. 2019 Nov;156(5):826-833. doi: 10.1016/j.chest.2019.05.028. Epub 2019 Jun 29. Chest. 2019. PMID: 31265837 Review. No abstract available.
Lung function trajectories in patients with idiopathic pulmonary fibrosis.
Neely ML, Hellkamp AS, Bender S, Todd JL, Liesching T, Luckhardt TR, Oldham JM, Raj R, White ES, Palmer SM. Neely ML, et al. Among authors: luckhardt tr. Respir Res. 2023 Aug 24;24(1):209. doi: 10.1186/s12931-023-02503-5. Respir Res. 2023. PMID: 37612608 Free PMC article.
NADPH oxidases in lung health and disease.
Bernard K, Hecker L, Luckhardt TR, Cheng G, Thannickal VJ. Bernard K, et al. Among authors: luckhardt tr. Antioxid Redox Signal. 2014 Jun 10;20(17):2838-53. doi: 10.1089/ars.2013.5608. Epub 2014 Jan 3. Antioxid Redox Signal. 2014. PMID: 24093231 Free PMC article. Review.
44 results